x

Search for a research project

* (*) mandatory field

68 Result(s)

Sort by

Funded by an IRDiRC member =

Research projects

AUSTRIA

WIEN
WIEN

Multifunctional Role of the PAX5-JAK2 Oncoprotein in B Cell Leukemia
Vienna Biocenter
Research Institute of Molecular Pathology

AUSTRIA

WIEN
WIEN

Translational Research in Childhood Acute Lymphoblastic Leukemia (TRANSCALL)
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

AUSTRIA

WIEN
WIEN

Stat5 serine phosphorylation in Bcr/Abl-induced leukemia
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

AUSTRIA

WIEN
WIEN

CDK8 - a weapon to arm NK cells against leukemia
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

AUSTRIA

WIEN
WIEN

Uncoupling CDK6 from p16INK4A - effects for hematopoiesis and lymphomagenesis
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

FINLAND

Finland
TAMPERE

Funded by an IRDiRC memberThe pathogenesis of childhood acute leukemia
University of Tampere
Tampere Center for Child Health Research

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Baden-Württemberg
MANNHEIM

GERMANY

Bayern
ERLANGEN

Late Effects Surveillance System (LESS) for oncological diseases in children und adolescents
Kinder- und Jugendklinik des Universitätsklinikums Erlangen
Kinder- und Jugendklinik

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

Funded by an IRDiRC memberTurbiCAR : Preclinical evaluation
Institution: Information not provided - DE

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

Funded by an IRDiRC memberTurbiCAR : Production of the anti-CD19 target module
Institution: Information not provided - DE

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Berlin
BERLIN

ALL-REZ BFM: Observational study biobank for children with Acute Lymphoblastic Leukemia
Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie

GERMANY

Hessen
FRANKFURT AM MAIN

Pathological gene products and their disease mechanisms: Oncogenic cytokine signaling in acute lymphoblastic leukemia (P2)
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Medizinische Klinik II - Hämatologie und Onkologie

GERMANY

Sachsen
DRESDEN

ITALY

UMBRIA
PERUGIA

Characterization of chromosomal breakpoints in hematological malignancies using molecular cytogenetics
Università degli Studi di Perugia - Ospedale S. Maria della Misericordia
Laboratorio di Genetica Ematologica e Oncologica

POLAND

Wroclaw
WROCLAW

PORTUGAL

NORTE
PORTO

Clinical implications of activation of PI3K/Akt signaling pathway in primary adult acute lymphoblastic leukemia.
Hospital de Santo António - Centro Hospitalar do Porto
Unidade de Imunologia Clínica

PORTUGAL

SUL
LISBOA

SWEDEN

Skane
LUND

Hematopoietic stem cell proliferation in development and in acute lymphoblastic leukemia
Lund University
Department of Experimental Medical Science

SWEDEN

Stockholms läns landsting
STOCKHOLM

Transcriptional mechanisms by Notch and E2A proteins in lymphocyte development and ALL
Karolinska Institutet - Solna
The Institute of Environmental Medicine

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Funded by an IRDiRC memberBiomarkers of vincristine-induced peripheral neuropathy
Institution: Information not provided - US

GERMANY

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

PK 2005 02: Pharmacogenetics and metabolism of cyclophosphamide in paediatric non-Hodgkin's Lymphoma
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

UNITED KINGDOM

West Midlands
BIRMINGHAM

Observational study of EBV associated NK/T cell malignancies
University of Birmingham
Institute for cancer studies

FRANCE

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

GERMANY

Baden-Württemberg
HEIDELBERG

Funded by an IRDiRC memberERA-NET TRANSCAN: TORPEDO - Targeting Of Resistance in PEDiatric Oncology (coordination)
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

ITALY

LOMBARDIA
MILANO

RARECARE: surveillance of rare cancers in Europe (coordination)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. di Epidemiologia Valutativa

UNITED KINGDOM

Greater London
LONDON

Funded by an IRDiRC memberUK Infrastructure for Large-scale Clinical Genomics Research
Barts and The London School of Medicine and Dentistry
William Harvey Research Institute

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Funded by an IRDiRC memberNewcastle University Single Cell Functional Genomics Unit (NUSCU)
Newcastle University
Institute of Genetic Medicine

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

EPOC: European paediatric oncology off-patent medicines consortium (coordination)
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Multicentric Research projects